Trial · NCT00557817
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
NCT00557817, Phase 2, Phase 3, Completed, University of Liege
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT). Trials, record NCT00557817. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00557817
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
- NCT number
- NCT00557817
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 125 participants, actual
- Lead sponsor
- University of Liege
- Conditions
- Hematological Malignancies
- Interventions
- Darbepoetin alpha (Aranesp), Iron saccharate (Venofer)
- First posted
- 2007-11-14
- Last updated
- 2010-01-11
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Median time to achieve hemoglobin (Hb) level > 13 g/dL in each arm. | 126 days after hematocrit (HCT) | |
| Primary | Proportion of complete correctors (i.e. patients reaching Hb > 13 g/dL) before day 126 in each arm. | 126 days after HCT | |
| Secondary | Median time to increase Hb level by > 2 g/dL in each arm. | 126 days after HCT | |
| Secondary | Proportion of responders (i.e. patients increasing Hb by > 2 g/dL) before day 126 in each arm. | 126 days after HCT | |
| Secondary | Proportion of correctors (i.e. patients reaching Hb > 12 g/dL) before day 126 in each arm. | 126 days after HCT | |
| Secondary | Proportion of patients requiring red blood cell transfusions between day 28 and day 126 in each arm. | 126 days after HCT | |
| Secondary | Total number of red blood cell transfusions between day 28 and day 126 in each arm. | 126 days after HCT | |
| Secondary | Area under the curve of mean Hb level between day 28 and day 126 after the transplant in each arm. | 126 days after HCT | |
| Secondary | Mean Hb values on days 42, 56, 70, 84, 98, 112, and 126 in each arm. | 126 days after HCT | |
| Secondary | Mean change in Quality Of Life (QOL) measurements between day 28 and day 126 in each arm. | 126 days after HCT |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00557817
GET https://conductscience.org/api/trials/v1/NCT00557817/registered